Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Clover Health Investments, Corp.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SECOND QUARTER 2025 MEDICARE ADVANTAGE MEMBERSHIP OF 106,323, UP 32% YEAR-OVER-YEAR SECOND QUARTER 2025 TOTAL REVENUES OF $478 MILLION, UP 34% YEAR-OVER-YEAR SECOND QUARTER 2025 PROFITABILITY METRICS WITH GAAP NET LOSS OF $11 MILLION, ADJUSTED EBITDA OF $17 MILLION, AND ADJUSTED NET INCOME OF $17 MILLION UPDATES FULL YEAR 2025 GUIDANCE: INCREASES AVERAGE MEDICARE ADVANTAGE MEMBERSHIP TO 104,000 - 108,000, REPRESENTING 32% GROWTH YEAR-OVER-YEAR AT THE MIDPOINT MAINTAINS INSURANCE REVENUE BETWEEN $1.800BILLION AND $1.875BILLION, REPRESENTING 37% GROWTH YEAR-OVER-YEAR AT THE MIDPOINT IMPROVES ADJUSTED SG&A TO BETWEEN $335 MILLION AND $345 MILLION, REPRESENTING ADJUSTED SG&A AS A PERCENTAGE OF TOTAL REVENUES BETWEEN 18% - 19% MAINTAINS ADJUSTED EBITDA PROFITABILITY BETWEEN $50MILLION AND $70MILLION MAINTAINS ADJUSTED NET INCOME BETWEEN $50MILLION AND $70MILLION EXPECTS INSURANCE BER NOW BETWEEN 88.5% - 89.5% WILMINGTON, DEL., AUG. 05, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY), TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER 2025.

CLOVER HEALTH REPORTS SECOND QUARTER 2025 RESULTS; DELIVERING STRONG SUSTAINABLE GROWTH

NEW WHITEPAPER SHOWS THAT A RELATIONSHIP WITH A PRIMARY CARE PHYSICIAN (PCP) WHO USES COUNTERPART ASSISTANT IS CORRELATED WITH MORE FREQUENT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DIAGNOSIS, INCREASED SPECIALTY CARE, AND MEANINGFUL REDUCTIONS IN HOSPITALIZATIONS (15% LOWER) AND 30-DAY READMISSIONS (18% LOWER).

PRIMARY CARE PHYSICIAN USE OF COUNTERPART ASSISTANT TECHNOLOGY LINKED TO BETTER HEALTH OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

WILMINGTON, DEL., JULY 31, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER HEALTH), A PHYSICIAN ENABLEMENT COMPANY BRINGING ACCESS TO GREAT HEALTHCARE TO EVERYONE ON MEDICARE, STRONGLY SUPPORTS THE WHITE HOUSE AND CENTERS FOR MEDICARE & MEDICAID SERVICES' (CMS) ANNOUNCEMENT CALLING ON THE HEALTHCARE INDUSTRY TO TEAR DOWN DIGITAL WALLS AND BUILD A TRULY PATIENT-CENTRIC, INTEROPERABLE ECOSYSTEM.

CLOVER HEALTH APPLAUDS WHITE HOUSE AND CMS' PUSH TO TEAR DOWN DIGITAL WALLS, ACCELERATING AND SIMPLIFYING ACCESS TO HEALTH DATA FOR PATIENTS AND THEIR CLINICIANS

WILMINGTON, DEL., JULY 29, 2025 (GLOBE NEWSWIRE) -- COUNTERPART HEALTH, INC. (COUNTERPART), A WHOLLY OWNED SUBSIDIARY OF CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY) AND A LEADING AI-POWERED PHYSICIAN-ENABLEMENT PLATFORM, TODAY ANNOUNCED THE APPOINTMENT OF VICKY BRUNER AS VICE PRESIDENT OF OPERATIONS.

COUNTERPART HEALTH APPOINTS VICKY BRUNER AS VICE PRESIDENT OF OPERATIONS TO SUPPORT EXPANSION AND CUSTOMER EXECUTION

PARIS--(BUSINESS WIRE)--TOTALENERGIES (PARIS:TTE) (LSE:TTE) (NYSE:TTE) ANNOUNCES THE START OF PRODUCTION FROM THE BEGONIA AND CLOV PHASE 3 OFFSHORE PROJECTS, LEVERAGING ULLAGE IN THE PAZFLOR AND CLOV FLOATING PRODUCTION, STORAGE AND OFFLOADING UNITS (FPSO) TO ADD A TOTAL OF 60,000 BARRELS A DAY OF NEW PRODUCTION. THESE TWO SUBSEA TIE-BACK PROJECTS DELIVER ADDITIONAL PRODUCTION LEVERAGING AVAILABLE CAPACITY ON EXISTING FPSO'S AND AS SUCH HAVE LOW MARGINAL COSTS AND LOW CARBON INTENSITIES. BEGONI.

TOTALENERGIES - ANGOLA: START-UP OF BEGONIA AND CLOV PHASE 3 OFFSHORE PROJECTS

WILMINGTON, DEL., JULY 21, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY), TODAY ANNOUNCED THAT ITS CHIEF FINANCIAL OFFICER, PETER KUIPERS, WILL PRESENT AT THE CANACCORD GENUITY 45TH ANNUAL GROWTH CONFERENCE ON TUESDAY, AUGUST 12, 2025, AT 11:00 A.M. EASTERN TIME.

CLOVER HEALTH TO PARTICIPATE IN UPCOMING CANACCORD GENUITY 45TH ANNUAL GROWTH CONFERENCE

WILMINGTON, DEL., JULY 17, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER HEALTH), A PHYSICIAN ENABLEMENT COMPANY BRINGING ACCESS TO GREAT HEALTHCARE TO EVERYONE ON MEDICARE, TODAY ANNOUNCED THE APPOINTMENT OF JOSEPH (JOE) OLDAKOWSKI AS VICE PRESIDENT OF FINANCE AND CONTROLLER. IN THIS ROLE, MR. OLDAKOWSKI REPORTS TO CHIEF FINANCIAL OFFICER PETER KUIPERS AND WILL LEAD CLOVER'S CORPORATE ACCOUNTING, GAAP, SEC, AND STATUTORY FINANCIAL REPORTING AND TAX FUNCTION.

CLOVER HEALTH APPOINTS JOSEPH OLDAKOWSKI AS VICE PRESIDENT OF FINANCE AND CONTROLLER

WILMINGTON, DEL., JULY 09, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER HEALTH), A LEADING MEDICARE ADVANTAGE COMPANY COMMITTED TO AFFORDABLE, HIGH-QUALITY CARE, TODAY ANNOUNCED THE LAUNCH OF A NEW COMMUNITY-BASED PHARMACY PILOT PROGRAM ACROSS NEW JERSEY.

CLOVER HEALTH LAUNCHES NEW JERSEY COMMUNITY PHARMACY PROGRAM IN PARTNERSHIP WITH IPC'S ICARE+ NETWORK

WILMINGTON, DEL., JULY 08, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY), TODAY ANNOUNCED THAT IT WILL RELEASE ITS FINANCIAL RESULTS AFTER THE MARKET CLOSES ON TUESDAY, AUGUST 5, 2025. COMPANY MANAGEMENT WILL HOST A CONFERENCE CALL AND WEBCAST AT 5:00 P.M. EASTERN TIME ON THE SAME DAY TO DISCUSS THE COMPANY'S BUSINESS AND FINANCIAL PERFORMANCE FOR THE QUARTER.

CLOVER HEALTH TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 5, 2025

WILMINGTON, DEL., JUNE 30, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER HEALTH), ANNOUNCED THAT IT IS SET TO JOIN THE BROAD-MARKET RUSSELL 3000 INDEX, EFFECTIVE AFTER THE US MARKET OPENS TODAY, JUNE 30, 2025, AS PART OF THE 2025 RUSSELL INDEXES RECONSTITUTION.

Clover Health Investments, Corp.

CLOV

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Clover Health Investments, Corp.

CLOV.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

CLOV